The endometrial cancer market space will experience significant growth during the forecast period of 2025--2034. The future is brighter for patients with endometrial cancer. Targeted agents and ...

Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall ...

NUTLEY, N.J., Nov. 3, 2025 /PRNewswire/ -- Eisai announced today the presentation of clinical research in gynecologic oncology during the International Gynecologic Cancer Society (IGCS) 2025 Annual ...

The global endometrial cancer market is on course for steady expansion, projected to reach nearly $39 billion by 2030. Growth ...

Endometrial Cancer is a cancer of the endometrium a lining of the uterus If diagnosed timely it is possible to treat it ...

Understanding the early signs of endometrial cancer coming back is important. Being aware, attending check-ups, and acting ...

Endometrial cancer, the most common uterine cancer, often begins with subtle symptoms like abnormal bleeding, which can be ...

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

Cancer incidence is rising around the world, but an international study is challenging the popular narrative that young ...

The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...

Uterine or endometrial cancer is cancer that occurs in the uterus or the endometrial lining of the uterus. The risk of uterine cancer increases with age, with most cases occurring after menopause.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Gini F. Fleming, ...